FIELD: medicine. SUBSTANCE: method involves measuring lipid hydroperoxides (LHP) and superoxydysmutase (SOD) contents in erysipelatous inflammation patients blood plasma, and general peroxydase activity (GPA), malonic dialdehyde (MDA) concentration and catalase ( C) activity in blood serum. Oxidation-antioxidation coefficient is calculated from a formula of OAC= (LHPx/LHPn* MDAx/MDAn* GPAx/GPAn)/(SODx/SODn*Cx/Cn), where LHPx, MDAx, GPAx, SODx, Cx are the biochemical values under examination in erysilepelas patients, and LHPn, MDAn, GPAn, SODn, Cn are the biochemical values under examination in healthy patients. OAC value being less than 1.6 conditional units, erysipelatous inflammation recurrence is predicted to take place in the nearest 6 months. EFFECT: reliable and accurate prognosis method. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING BULLOUS AND HEMORRHAGIC FORMS OF ERYSIPELAS | 1999 |
|
RU2148258C1 |
| METHOD FOR DETECTING THE MERIT FOR PRESCRIBING EMOXYPIN FOR ERYSIPELAS-SUFFERING PATIENTS | 2003 |
|
RU2232995C1 |
| METHOD FOR DETERMINING TOXIC DIPHTHERIA DEVELOPMENT COURSE | 1997 |
|
RU2135998C1 |
| METHOD OF DETERMINING INDICATIONS FOR ADMINISTERING EMOXIPIN IN TREATMENT OF TOXIC DIPHTHERIA | 1998 |
|
RU2137128C1 |
| METHOD OF TREATMENT OF PATIENTS WITH ERYSIPELAS | 1995 |
|
RU2120286C1 |
| METHOD FOR PREDICTING CHRONIC RELAPSING DISEASE COURSE IN PERSONS RECOVERED FROM PRIMARY ERYSIPELAS | 1995 |
|
RU2101701C1 |
| METHOD OF ERYSIPELAS RECIDIVATION PREDICTION | 2006 |
|
RU2332847C2 |
| RECURRENT ERYSIPELAS PREVENTION METHOD | 2007 |
|
RU2354144C1 |
| METHOD OF TREATING ERYSIPELAS | 2012 |
|
RU2502530C1 |
| METHOD FOR PREDICTION OF HEMORRHAGIC FORMS OF DISEASE DEVELOPING IN PATIENTS, SUFFERING FROM ERYSIPELAS OF LOWER EXTREMITIES | 2015 |
|
RU2601370C1 |
